OncoSec Medical and Plexxikon Collaborate to Explore Combination Immunotherapy in Preclinical Tumor Studies

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, today announced a preclinical collaboration with Plexxikon Inc., a member of



from Content Keyword RSS http://ift.tt/11nPfMj

via IFTTT